Ligand functional selectivity and quantitative pharmacology at G protein-coupled receptors

被引:62
作者
Stallaert, Wayne [1 ,2 ]
Christopoulos, Arthur [3 ,4 ]
Bouvier, Michel [1 ,2 ]
机构
[1] Univ Montreal, Dept Biochem, Montreal, PQ H3C 3J7, Canada
[2] Univ Montreal, Inst Res Immunol & Canc, Montreal, PQ H3C 3J7, Canada
[3] Monash Univ, Monash Inst Pharmaceut Sci, Clayton, Vic 3800, Australia
[4] Monash Univ, Dept Pharmacol, Clayton, Vic 3800, Australia
关键词
efficacy; GPCRs; potency; selectivity; signaling; MUSCARINIC ACETYLCHOLINE-RECEPTORS; BETA(2) ADRENERGIC-RECEPTOR; 7 TRANSMEMBRANE RECEPTORS; DELTA-OPIOID RECEPTORS; CRYSTAL-STRUCTURE; LIVING CELLS; ACTIVE STATE; CONFORMATIONAL-CHANGES; RAPID DESENSITIZATION; CONSTITUTIVE ACTIVITY;
D O I
10.1517/17460441.2011.586691
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Introduction: In recent years, it has become clear that individual GPCRs can elicit multiple G-protein-dependent and -independent cellular responses. This has led to the discovery that certain ligands can differentially modulate these responses, a concept known as functional selectivity. Areas covered: In this review, the authors describe the various manifestations of functional selectivity and its potential implication in drug discovery. The authors provide a historical perspective of the observations and methodologies that led to the evolution of this concept. The authors also describe the proposed molecular mechanisms responsible for the engagement of distinct subsets of signaling repertoire by different ligands. The review offers the reader a synthetic view of how functional selectivity could be used in the design of safer and more effective drugs. Expert opinion: Our better understanding of the various ways by which compounds modulate GPCR activity has led to a parallel expansion of the terminology used to describe these phenomena. The authors propose a standardization of this nomenclature as an essential step to both simplify and clarify the language used among researchers to facilitate future collaboration and discovery of these important therapeutic targets. Such clarification of the various aspects of functional selectivity, coupled with the development of tools for effective monitoring, will undoubtedly bring this emerging concept into the general paradigm of drug discovery at GPCRs.
引用
收藏
页码:811 / 825
页数:15
相关论文
共 116 条
[1]   Direct observation of G-protein binding to the human δ-opioid receptor using plasmon-waveguide resonance spectroscopy [J].
Alves, ID ;
Salamon, Z ;
Varga, E ;
Yamamura, HI ;
Tollin, G ;
Hruby, VJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (49) :48890-48897
[2]   Internalization and Src activity regulate the time course of ERK activation by delta opioid receptor ligands [J].
Audet, N ;
Paquin-Gobeil, M ;
Landry-Paquet, O ;
Schiller, PW ;
Piñeyro, G .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (09) :7808-7816
[3]   Bioluminescence resonance energy transfer assays reveal ligand-specific conformational changes within preformed signaling complexes containing δ-opioid receptors and heterotrimeric G proteins [J].
Audet, Nicolas ;
Gales, Celine ;
Archer-Lahlou, Elodie ;
Vallieres, Marc ;
Schiller, Peter W. ;
Bouvier, Michel ;
Pineyro, Graciela .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (22) :15078-15088
[4]   β-Arrestin-mediated activation of MAPK by inverse agonists reveals distinct active conformations for G protein-coupled receptors [J].
Azzi, M ;
Charest, PG ;
Angers, S ;
Rousseau, G ;
Kohout, T ;
Bouvier, M ;
Piñeyro, G .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (20) :11406-11411
[5]   Effector pathway-dependent relative efficacy at serotonin type 2A and 2C receptors: Evidence for agonist-directed trafficking of receptor stimulus [J].
Berg, KA ;
Maayani, S ;
Goldfarb, J ;
Scaramellini, C ;
Leff, P ;
Clarke, WP .
MOLECULAR PHARMACOLOGY, 1998, 54 (01) :94-104
[6]   How to Design an Opioid Drug That Causes Reduced Tolerance and Dependence [J].
Berger, Amy Chang ;
Whistler, Jennifer L. .
ANNALS OF NEUROLOGY, 2010, 67 (05) :559-569
[7]   The endothelin subtype A receptor undergoes agonist- and antagonist-mediated internalization in the absence of signaling [J].
Bhowmick, N ;
Narayan, P ;
Puett, D .
ENDOCRINOLOGY, 1998, 139 (07) :3185-3192
[8]   Selective ligand-induced stabilization of active and desensitized parathyroid hormone type 1 receptor conformations [J].
Bisello, A ;
Chorev, M ;
Rosenblatt, M ;
Monticelli, L ;
Mierke, DF ;
Ferrari, SL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (41) :38524-38530
[9]   OPERATIONAL MODELS OF PHARMACOLOGICAL AGONISM [J].
BLACK, JW ;
LEFF, P .
PROCEEDINGS OF THE ROYAL SOCIETY SERIES B-BIOLOGICAL SCIENCES, 1983, 220 (1219) :141-162
[10]   GPCR interacting proteins (GIP) [J].
Bockaert, J ;
Fagni, L ;
Dumuis, A ;
Marin, P .
PHARMACOLOGY & THERAPEUTICS, 2004, 103 (03) :203-221